NB
RMD icon

NBT Bank’s ResMed RMD Stock Holding History

NBT Bank’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$42.9K Hold
220
– – ﹤0.01% 534
2026
Q1 		$49.4K Buy
220
+15
+7% +$3.74K ﹤0.01% 505
2025
Q4 		$49.4K Sell
205
-47
-19% -$12K ﹤0.01% 499
2025
Q3 		$69K Buy
252
+47
+23% +$12.8K ﹤0.01% 469
2025
Q2 		$52.9K Hold
205
– – ﹤0.01% 495
2025
Q1 		$45.9K Hold
205
– – ﹤0.01% 502
2024
Q4 		$46.9K Hold
205
– – ﹤0.01% 507
2024
Q3 		$50K Buy
+205
New +$45.8K ﹤0.01% 523

Other funds holding RMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

NBT Bank's RMD Position: Q2 2026 in Review

NBT Bank held its ResMed (RMD) position steady in Q2 2026 at 220 shares worth $42.9K. The position accounts for ﹤0.01% of the portfolio, ranked #534.

NBT Bank first reported a position in RMD in Q3 2024 and has held it in 8 quarters since. The position peaked at $69K in Q3 2025. 889 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

  • NBT Bank held 220 shares of ResMed worth $42.9K as of Q2 2026.
  • NBT Bank left its ResMed share count unchanged in Q2 2026.
  • ResMed made up ﹤0.01% of NBT Bank's portfolio in Q2 2026, its #534 holding.
  • NBT Bank first reported a position in ResMed in Q3 2024 and has held it in 8 quarters since.
  • NBT Bank's ResMed position peaked at $69K in Q3 2025.
  • 889 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on NBT Bank's 13F filing for Q2 2026, filed 29 Jul 2026.